Home > News > 454 Life Sciences Receives $2.4 million NIH Grant
May 19th, 2004
454 Life Sciences Receives $2.4 million NIH Grant
454 Life Sciences, a majority-owned subsidiary of CuraGen Corporation today announced that the Company has received a two-year, $2.4 million grant from the National Human Genome Research Institute, one of the National Institutes of Health. The grant will help fund the scale up of 454 Life Sciences' technology toward sequencing of larger genomes.
Nanometrics Announces Upcoming Investor Events November 19th, 2014
Eight19 secures £1m funding: Investment to develop production technology, and expand commercial activities for organic photovoltaics November 19th, 2014
Arrowhead to Present at Upcoming Conferences November 15th, 2014
Harris & Harris Group Reports Financial Statements as of September 30, 2014 November 11th, 2014